

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.60253734 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.60253734 |
| 3 | histone H3-K36 demethylation (GO:0070544) | 4.81408684 |
| 4 | positive regulation of histone deacetylation (GO:0031065) | 4.10280052 |
| 5 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.06760632 |
| 6 | regulation of NFAT protein import into nucleus (GO:0051532) | 4.01582242 |
| 7 | histone H3-K9 demethylation (GO:0033169) | 3.86108999 |
| 8 | Golgi transport vesicle coating (GO:0048200) | 3.66874479 |
| 9 | COPI coating of Golgi vesicle (GO:0048205) | 3.66874479 |
| 10 | protein localization to endosome (GO:0036010) | 3.63833513 |
| 11 | activation of Rac GTPase activity (GO:0032863) | 3.61855982 |
| 12 | heterochromatin organization (GO:0070828) | 3.47877717 |
| 13 | positive thymic T cell selection (GO:0045059) | 3.38402001 |
| 14 | pre-miRNA processing (GO:0031054) | 3.32336748 |
| 15 | RNA stabilization (GO:0043489) | 3.26250411 |
| 16 | mRNA stabilization (GO:0048255) | 3.26250411 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.25226431 |
| 18 | nuclear pore complex assembly (GO:0051292) | 3.20051339 |
| 19 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.13630605 |
| 20 | cellular protein complex localization (GO:0034629) | 3.11632598 |
| 21 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.09309146 |
| 22 | mitotic chromosome condensation (GO:0007076) | 3.07569674 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.06290817 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.06290817 |
| 25 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.04352939 |
| 26 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.02685317 |
| 27 | regulation of translational fidelity (GO:0006450) | 3.01915318 |
| 28 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.01603831 |
| 29 | cell-substrate adherens junction assembly (GO:0007045) | 3.01199665 |
| 30 | focal adhesion assembly (GO:0048041) | 3.01199665 |
| 31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.00969213 |
| 32 | peptidyl-lysine dimethylation (GO:0018027) | 3.00205311 |
| 33 | regulation of ARF GTPase activity (GO:0032312) | 2.99590319 |
| 34 | maternal placenta development (GO:0001893) | 2.99497980 |
| 35 | adherens junction assembly (GO:0034333) | 2.99339520 |
| 36 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.99307614 |
| 37 | positive regulation of lamellipodium assembly (GO:0010592) | 2.94809691 |
| 38 | regulation of RNA export from nucleus (GO:0046831) | 2.94103175 |
| 39 | synaptonemal complex assembly (GO:0007130) | 2.93742414 |
| 40 | thymic T cell selection (GO:0045061) | 2.88470861 |
| 41 | B cell receptor signaling pathway (GO:0050853) | 2.87786758 |
| 42 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.87430822 |
| 43 | positive regulation of protein deacetylation (GO:0090312) | 2.82516120 |
| 44 | NLS-bearing protein import into nucleus (GO:0006607) | 2.82450250 |
| 45 | cortical actin cytoskeleton organization (GO:0030866) | 2.80840140 |
| 46 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.78818515 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.75412695 |
| 48 | cell-substrate junction assembly (GO:0007044) | 2.74231161 |
| 49 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.73892196 |
| 50 | protein export from nucleus (GO:0006611) | 2.73592270 |
| 51 | regulation of early endosome to late endosome transport (GO:2000641) | 2.71627182 |
| 52 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.69841282 |
| 53 | positive T cell selection (GO:0043368) | 2.69507995 |
| 54 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.68258392 |
| 55 | positive regulation of receptor recycling (GO:0001921) | 2.68052261 |
| 56 | positive regulation by symbiont of host defense response (GO:0052509) | 2.66400308 |
| 57 | modulation by symbiont of host defense response (GO:0052031) | 2.66400308 |
| 58 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.66400308 |
| 59 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.66400308 |
| 60 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.66400308 |
| 61 | modulation by symbiont of host immune response (GO:0052553) | 2.66400308 |
| 62 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.64846227 |
| 63 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.63687460 |
| 64 | NIK/NF-kappaB signaling (GO:0038061) | 2.62680403 |
| 65 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.61482543 |
| 66 | regulation of chromatin binding (GO:0035561) | 2.61278930 |
| 67 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.60908562 |
| 68 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.59695793 |
| 69 | negative thymic T cell selection (GO:0045060) | 2.58422417 |
| 70 | regulation of gamma-delta T cell activation (GO:0046643) | 2.58359664 |
| 71 | receptor recycling (GO:0001881) | 2.57219789 |
| 72 | histone lysine demethylation (GO:0070076) | 2.56693606 |
| 73 | T cell selection (GO:0045058) | 2.56623744 |
| 74 | basement membrane organization (GO:0071711) | 2.56622616 |
| 75 | positive regulation of protein dephosphorylation (GO:0035307) | 2.56150969 |
| 76 | negative regulation of anoikis (GO:2000811) | 2.55125416 |
| 77 | positive regulation of Rap GTPase activity (GO:0032854) | 2.54655244 |
| 78 | body morphogenesis (GO:0010171) | 2.54545031 |
| 79 | adaptation of signaling pathway (GO:0023058) | 2.54479172 |
| 80 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.54239313 |
| 81 | negative regulation of histone methylation (GO:0031061) | 2.53936387 |
| 82 | modulation by symbiont of host cellular process (GO:0044068) | 2.53763412 |
| 83 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.52752564 |
| 84 | skin morphogenesis (GO:0043589) | 2.52367012 |
| 85 | barbed-end actin filament capping (GO:0051016) | 2.52317588 |
| 86 | protein retention in ER lumen (GO:0006621) | 2.52221317 |
| 87 | DNA synthesis involved in DNA repair (GO:0000731) | 2.52029809 |
| 88 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.51426594 |
| 89 | signal complex assembly (GO:0007172) | 2.50990579 |
| 90 | positive regulation of B cell differentiation (GO:0045579) | 2.50242936 |
| 91 | response to peptidoglycan (GO:0032494) | 2.49976855 |
| 92 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.49499207 |
| 93 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.49499207 |
| 94 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.49499207 |
| 95 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.49472216 |
| 96 | regulation of sister chromatid cohesion (GO:0007063) | 2.49320458 |
| 97 | corticosteroid receptor signaling pathway (GO:0031958) | 2.47964195 |
| 98 | histone demethylation (GO:0016577) | 2.47755816 |
| 99 | negative T cell selection (GO:0043383) | 2.47692318 |
| 100 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.47375850 |
| 101 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.46882071 |
| 102 | apoptotic process involved in morphogenesis (GO:0060561) | 2.46528953 |
| 103 | embryonic process involved in female pregnancy (GO:0060136) | 2.45092610 |
| 104 | regulation of histone H3-K27 methylation (GO:0061085) | 2.45083857 |
| 105 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.44347421 |
| 106 | response to laminar fluid shear stress (GO:0034616) | 2.44143290 |
| 107 | growth hormone receptor signaling pathway (GO:0060396) | 2.44022533 |
| 108 | histone H2B ubiquitination (GO:0033523) | 2.43506897 |
| 109 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.43476535 |
| 110 | pinocytosis (GO:0006907) | 2.42371982 |
| 111 | negative regulation of B cell proliferation (GO:0030889) | 2.42295321 |
| 112 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.42258897 |
| 113 | chromatin assembly (GO:0031497) | 2.42055512 |
| 114 | regulation of extracellular matrix disassembly (GO:0010715) | 2.41603157 |
| 115 | macrophage activation involved in immune response (GO:0002281) | 2.41468350 |
| 116 | hypotonic response (GO:0006971) | 2.39926880 |
| 117 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.38548247 |
| 118 | natural killer cell differentiation (GO:0001779) | 2.38373642 |
| 119 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.37235975 |
| 120 | positive regulation of lamellipodium organization (GO:1902745) | 2.36884073 |
| 121 | epithelial cell-cell adhesion (GO:0090136) | 2.36862502 |
| 122 | mannose metabolic process (GO:0006013) | 2.36434432 |
| 123 | actin nucleation (GO:0045010) | 2.36172367 |
| 124 | regulation of lipid kinase activity (GO:0043550) | 2.36027026 |
| 125 | response to nerve growth factor (GO:1990089) | 2.35719149 |
| 126 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.35719149 |
| 127 | embryonic body morphogenesis (GO:0010172) | 2.35460451 |
| 128 | regulation of mRNA stability (GO:0043488) | 2.35420942 |
| 129 | negative regulation of RNA splicing (GO:0033119) | 2.35229829 |
| 130 | positive regulation of lipid kinase activity (GO:0090218) | 2.34900808 |
| 131 | glycosphingolipid catabolic process (GO:0046479) | 2.34588758 |
| 132 | negative regulation of fatty acid transport (GO:2000192) | 2.34114384 |
| 133 | synaptonemal complex organization (GO:0070193) | 2.33939009 |
| 134 | morphogenesis of an endothelium (GO:0003159) | 2.33929257 |
| 135 | endothelial tube morphogenesis (GO:0061154) | 2.33929257 |
| 136 | cortical cytoskeleton organization (GO:0030865) | 2.33077777 |
| 137 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.33058528 |
| 138 | protein complex localization (GO:0031503) | 2.31344919 |
| 139 | negative regulation of cell size (GO:0045792) | 2.31162891 |
| 140 | regulation of anoikis (GO:2000209) | 2.31123737 |
| 141 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.30690739 |
| 142 | peptidyl-threonine modification (GO:0018210) | 2.30546102 |
| 143 | pore complex assembly (GO:0046931) | 2.30152357 |
| 144 | activation of JUN kinase activity (GO:0007257) | 2.29446400 |
| 145 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.28025382 |
| 146 | chromosome organization involved in meiosis (GO:0070192) | 2.27577871 |
| 147 | stress fiber assembly (GO:0043149) | 2.26158473 |
| 148 | mitotic sister chromatid cohesion (GO:0007064) | 2.26156943 |
| 149 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.26069221 |
| 150 | regulation of ARF protein signal transduction (GO:0032012) | 2.25920809 |
| 151 | germ cell migration (GO:0008354) | 2.25427074 |
| 152 | cellular extravasation (GO:0045123) | 2.24470894 |
| 153 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.24071953 |
| 154 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.23720607 |
| 155 | nuclear pore organization (GO:0006999) | 2.23637406 |
| 156 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.23543432 |
| 157 | regulation of B cell differentiation (GO:0045577) | 2.23159022 |
| 158 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.23055893 |
| 159 | peptidyl-threonine phosphorylation (GO:0018107) | 2.23055119 |
| 160 | regulation of leukocyte degranulation (GO:0043300) | 2.23019109 |
| 161 | receptor catabolic process (GO:0032801) | 2.22979647 |
| 162 | regulation of nuclease activity (GO:0032069) | 2.22937308 |
| 163 | leukocyte aggregation (GO:0070486) | 2.22689414 |
| 164 | vesicle coating (GO:0006901) | 2.22155082 |
| 165 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.21840052 |
| 166 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.21705165 |
| 167 | nerve growth factor signaling pathway (GO:0038180) | 2.21614917 |
| 168 | ER-nucleus signaling pathway (GO:0006984) | 2.21555162 |
| 169 | regulation of RNA stability (GO:0043487) | 2.21428322 |
| 170 | regulation of transcription from RNA polymerase I promoter (GO:0006356) | 2.21401797 |
| 171 | negative regulation of necroptotic process (GO:0060546) | 2.20940949 |
| 172 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.20367806 |
| 173 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.20367806 |
| 174 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.19637846 |
| 175 | positive regulation of nuclease activity (GO:0032075) | 2.19520870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 5.25118286 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.32260773 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.96326406 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.13854852 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.02709367 |
| 6 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.87567366 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.82282441 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.75966263 |
| 9 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.75303761 |
| 10 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.67106797 |
| 11 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.55419146 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.52981752 |
| 13 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.51658990 |
| 14 | * MAF_26560356_Chip-Seq_TH1_Human | 2.28150443 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.24912240 |
| 16 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.15646701 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.14631006 |
| 18 | UTX_26944678_Chip-Seq_JUKART_Human | 2.14531643 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11315433 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08968930 |
| 21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.07986846 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.02843239 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.02819915 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.01567342 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.00463280 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.97304767 |
| 27 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.90516522 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.86329256 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 1.85878699 |
| 30 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.85824870 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.83250073 |
| 32 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.82400557 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.79731758 |
| 34 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.73731240 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.72695249 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.72604722 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.71901988 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69278168 |
| 39 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.68055666 |
| 40 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.67050217 |
| 41 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.66585118 |
| 42 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.65170384 |
| 43 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61414254 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.59563068 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.59237619 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57467610 |
| 47 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.56356094 |
| 48 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.54791458 |
| 49 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.54138382 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.53971105 |
| 51 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.53118482 |
| 52 | KDM2B_26808549_Chip-Seq_K562_Human | 1.52320659 |
| 53 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52170569 |
| 54 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.50652519 |
| 55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.49952709 |
| 56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.49049359 |
| 57 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.46786545 |
| 58 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.43913479 |
| 59 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.43765322 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.43647908 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42936542 |
| 62 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.40773165 |
| 63 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40208105 |
| 64 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.39809185 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38166470 |
| 66 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.37834920 |
| 67 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35559800 |
| 68 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.35443731 |
| 69 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.34041705 |
| 70 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33779131 |
| 71 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.31091595 |
| 72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.30212587 |
| 73 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30174905 |
| 74 | MAF_26560356_Chip-Seq_TH2_Human | 1.29538256 |
| 75 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.29193406 |
| 76 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.27845374 |
| 77 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.26133846 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25232671 |
| 79 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.22943899 |
| 80 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19343271 |
| 81 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19177276 |
| 82 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.17508822 |
| 83 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.16886887 |
| 84 | ATF3_27146783_Chip-Seq_COLON_Human | 1.16522500 |
| 85 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.15803612 |
| 86 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.15744625 |
| 87 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.15521742 |
| 88 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15295347 |
| 89 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15170066 |
| 90 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14645138 |
| 91 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14447938 |
| 92 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13763172 |
| 93 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.13754815 |
| 94 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.13198324 |
| 95 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.12935015 |
| 96 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.12551320 |
| 97 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.12391724 |
| 98 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.12174614 |
| 99 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.11568882 |
| 100 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.11263968 |
| 101 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.10819897 |
| 102 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10760330 |
| 103 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10672580 |
| 104 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.10584375 |
| 105 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.09945921 |
| 106 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09593142 |
| 107 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.09384033 |
| 108 | * P68_20966046_ChIP-Seq_HELA_Human | 1.08677006 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08281075 |
| 110 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.07315776 |
| 111 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.06470091 |
| 112 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05874279 |
| 113 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.05829533 |
| 114 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05484688 |
| 115 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.03762759 |
| 116 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.03346291 |
| 117 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.02408803 |
| 118 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.02177771 |
| 119 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02083435 |
| 120 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01961081 |
| 121 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01897537 |
| 122 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00656603 |
| 123 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.00579114 |
| 124 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99809956 |
| 125 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99578712 |
| 126 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.99240546 |
| 127 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99160956 |
| 128 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99023522 |
| 129 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.98344780 |
| 130 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97531495 |
| 131 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.96961233 |
| 132 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95696532 |
| 133 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.94534527 |
| 134 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93727598 |
| 135 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.93095872 |
| 136 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.91945039 |
| 137 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.91150308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.20136147 |
| 2 | MP0003300_gastrointestinal_ulcer | 3.38077584 |
| 3 | MP0005076_abnormal_cell_differentiation | 3.26706960 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.18816223 |
| 5 | MP0010352_gastrointestinal_tract_polyps | 3.17690707 |
| 6 | MP0005451_abnormal_body_composition | 3.02793849 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.01209228 |
| 8 | MP0005409_darkened_coat_color | 2.78678602 |
| 9 | MP0009278_abnormal_bone_marrow | 2.62712785 |
| 10 | MP0008961_abnormal_basal_metabolism | 2.45252524 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.34114899 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.26401783 |
| 13 | MP0003436_decreased_susceptibility_to | 2.21062029 |
| 14 | MP0000569_abnormal_digit_pigmentation | 2.16050098 |
| 15 | MP0010307_abnormal_tumor_latency | 2.13119465 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.11813387 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.09839601 |
| 18 | MP0004233_abnormal_muscle_weight | 2.03120311 |
| 19 | MP0008260_abnormal_autophagy | 2.03038162 |
| 20 | MP0002796_impaired_skin_barrier | 2.00364515 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.99532914 |
| 22 | MP0000685_abnormal_immune_system | 1.96653881 |
| 23 | MP0001800_abnormal_humoral_immune | 1.95650964 |
| 24 | MP0002166_altered_tumor_susceptibility | 1.95139611 |
| 25 | MP0001790_abnormal_immune_system | 1.76537011 |
| 26 | MP0005387_immune_system_phenotype | 1.76537011 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.75425239 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.74893151 |
| 29 | MP0008438_abnormal_cutaneous_collagen | 1.73141324 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.69852103 |
| 31 | MP0004808_abnormal_hematopoietic_stem | 1.65180674 |
| 32 | MP0004510_myositis | 1.60266142 |
| 33 | MP0002398_abnormal_bone_marrow | 1.59523480 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.56712507 |
| 35 | MP0001819_abnormal_immune_cell | 1.55746493 |
| 36 | MP0000678_abnormal_parathyroid_gland | 1.54929927 |
| 37 | MP0002723_abnormal_immune_serum | 1.54625214 |
| 38 | MP0004858_abnormal_nervous_system | 1.50893822 |
| 39 | MP0002006_tumorigenesis | 1.48071104 |
| 40 | MP0002405_respiratory_system_inflammati | 1.45135061 |
| 41 | MP0003045_fibrosis | 1.44554222 |
| 42 | MP0005501_abnormal_skin_physiology | 1.44377679 |
| 43 | MP0004947_skin_inflammation | 1.42674167 |
| 44 | MP0005167_abnormal_blood-brain_barrier | 1.42388743 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.41419757 |
| 46 | MP0003866_abnormal_defecation | 1.40991113 |
| 47 | MP0005025_abnormal_response_to | 1.38920072 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.37527767 |
| 49 | MP0003448_altered_tumor_morphology | 1.36911794 |
| 50 | MP0000716_abnormal_immune_system | 1.35727510 |
| 51 | MP0002419_abnormal_innate_immunity | 1.35372799 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.33989728 |
| 53 | MP0006082_CNS_inflammation | 1.32716020 |
| 54 | MP0002060_abnormal_skin_morphology | 1.30172728 |
| 55 | MP0005666_abnormal_adipose_tissue | 1.29508193 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.29136964 |
| 57 | MP0002722_abnormal_immune_system | 1.26760786 |
| 58 | MP0000689_abnormal_spleen_morphology | 1.26402291 |
| 59 | MP0009333_abnormal_splenocyte_physiolog | 1.25485482 |
| 60 | MP0002089_abnormal_postnatal_growth/wei | 1.25090393 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 1.21798568 |
| 62 | MP0005310_abnormal_salivary_gland | 1.20425532 |
| 63 | MP0005671_abnormal_response_to | 1.17030822 |
| 64 | MP0003763_abnormal_thymus_physiology | 1.16003791 |
| 65 | MP0001216_abnormal_epidermal_layer | 1.15061704 |
| 66 | MP0000858_altered_metastatic_potential | 1.14227393 |
| 67 | MP0003453_abnormal_keratinocyte_physiol | 1.14181688 |
| 68 | MP0002429_abnormal_blood_cell | 1.14105294 |
| 69 | MP0002909_abnormal_adrenal_gland | 1.13811143 |
| 70 | MP0009840_abnormal_foam_cell | 1.12392327 |
| 71 | MP0000490_abnormal_crypts_of | 1.10998197 |
| 72 | MP0000733_abnormal_muscle_development | 1.09205695 |
| 73 | MP0002086_abnormal_extraembryonic_tissu | 1.08789623 |
| 74 | MP0005623_abnormal_meninges_morphology | 1.08112315 |
| 75 | MP0005023_abnormal_wound_healing | 1.07757483 |
| 76 | MP0005397_hematopoietic_system_phenotyp | 1.06857923 |
| 77 | MP0001545_abnormal_hematopoietic_system | 1.06857923 |
| 78 | MP0003828_pulmonary_edema | 1.06749560 |
| 79 | MP0005621_abnormal_cell_physiology | 1.05290523 |
| 80 | MP0001845_abnormal_inflammatory_respons | 1.04063072 |
| 81 | MP0000604_amyloidosis | 1.03164103 |
| 82 | MP0003693_abnormal_embryo_hatching | 1.02287097 |
| 83 | MP0004197_abnormal_fetal_growth/weight/ | 1.01647351 |
| 84 | MP0003091_abnormal_cell_migration | 1.00949084 |
| 85 | MP0003075_altered_response_to | 1.00627038 |
| 86 | MP0004381_abnormal_hair_follicle | 0.99960824 |
| 87 | MP0009672_abnormal_birth_weight | 0.99704579 |
| 88 | MP0003123_paternal_imprinting | 0.99468023 |
| 89 | MP0001958_emphysema | 0.99295150 |
| 90 | MP0005257_abnormal_intraocular_pressure | 0.97273690 |
| 91 | MP0003329_amyloid_beta_deposits | 0.96963779 |
| 92 | MP0000371_diluted_coat_color | 0.96367516 |
| 93 | MP0002148_abnormal_hypersensitivity_rea | 0.95875639 |
| 94 | MP0003941_abnormal_skin_development | 0.94910255 |
| 95 | MP0001730_embryonic_growth_arrest | 0.94439874 |
| 96 | MP0008770_decreased_survivor_rate | 0.94295589 |
| 97 | MP0002998_abnormal_bone_remodeling | 0.93630384 |
| 98 | MP0001849_ear_inflammation | 0.93601350 |
| 99 | MP0002396_abnormal_hematopoietic_system | 0.93343611 |
| 100 | MP0002009_preneoplasia | 0.93237669 |
| 101 | MP0006054_spinal_hemorrhage | 0.93000070 |
| 102 | MP0003183_abnormal_peptide_metabolism | 0.92266361 |
| 103 | MP0000465_gastrointestinal_hemorrhage | 0.92078552 |
| 104 | MP0001533_abnormal_skeleton_physiology | 0.91483328 |
| 105 | MP0003283_abnormal_digestive_organ | 0.90803350 |
| 106 | MP0005166_decreased_susceptibility_to | 0.89972597 |
| 107 | MP0001915_intracranial_hemorrhage | 0.88391254 |
| 108 | MP0002084_abnormal_developmental_patter | 0.88370222 |
| 109 | MP0000003_abnormal_adipose_tissue | 0.88195531 |
| 110 | MP0003115_abnormal_respiratory_system | 0.87249586 |
| 111 | MP0001853_heart_inflammation | 0.86347826 |
| 112 | MP0001348_abnormal_lacrimal_gland | 0.84480230 |
| 113 | MP0001851_eye_inflammation | 0.80023512 |
| 114 | MP0004264_abnormal_extraembryonic_tissu | 0.79943792 |
| 115 | MP0010678_abnormal_skin_adnexa | 0.79771387 |
| 116 | MP0000350_abnormal_cell_proliferation | 0.77498293 |
| 117 | MP0008057_abnormal_DNA_replication | 0.77473213 |
| 118 | MP0000313_abnormal_cell_death | 0.76783364 |
| 119 | MP0000477_abnormal_intestine_morphology | 0.76175779 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.75972594 |
| 121 | MP0004859_abnormal_synaptic_plasticity | 0.75655307 |
| 122 | MP0003111_abnormal_nucleus_morphology | 0.75279851 |
| 123 | MP0001873_stomach_inflammation | 0.75008937 |
| 124 | MP0002925_abnormal_cardiovascular_devel | 0.73536981 |
| 125 | MP0002019_abnormal_tumor_incidence | 0.73415713 |
| 126 | MP0008004_abnormal_stomach_pH | 0.73008104 |
| 127 | MP0009053_abnormal_anal_canal | 0.73005827 |
| 128 | MP0001697_abnormal_embryo_size | 0.72847367 |
| 129 | MP0002971_abnormal_brown_adipose | 0.72789693 |
| 130 | MP0009931_abnormal_skin_appearance | 0.72181415 |
| 131 | MP0003984_embryonic_growth_retardation | 0.71903495 |
| 132 | MP0000377_abnormal_hair_follicle | 0.71544989 |
| 133 | MP0002080_prenatal_lethality | 0.71433252 |
| 134 | MP0009703_decreased_birth_body | 0.71095042 |
| 135 | MP0005384_cellular_phenotype | 0.70905027 |
| 136 | MP0004272_abnormal_basement_membrane | 0.70117567 |
| 137 | MP0005375_adipose_tissue_phenotype | 0.67406496 |
| 138 | MP0004957_abnormal_blastocyst_morpholog | 0.67165681 |
| 139 | MP0000013_abnormal_adipose_tissue | 0.66117871 |
| 140 | MP0001672_abnormal_embryogenesis/_devel | 0.65427229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 3.60428587 |
| 2 | Cerebral aneurysm (HP:0004944) | 3.18631693 |
| 3 | Hyperparathyroidism (HP:0000843) | 2.99143375 |
| 4 | Subacute progressive viral hepatitis (HP:0006572) | 2.98648805 |
| 5 | Vertebral compression fractures (HP:0002953) | 2.87217429 |
| 6 | Volvulus (HP:0002580) | 2.78262830 |
| 7 | Hematochezia (HP:0002573) | 2.77995364 |
| 8 | Disinhibition (HP:0000734) | 2.73251523 |
| 9 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.65388453 |
| 10 | Cellulitis (HP:0100658) | 2.63940535 |
| 11 | Recurrent abscess formation (HP:0002722) | 2.62688172 |
| 12 | Macroorchidism (HP:0000053) | 2.60161338 |
| 13 | Protrusio acetabuli (HP:0003179) | 2.58090983 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 2.55351634 |
| 15 | Recurrent fungal infections (HP:0002841) | 2.50086607 |
| 16 | Premature rupture of membranes (HP:0001788) | 2.44806980 |
| 17 | Colitis (HP:0002583) | 2.43277576 |
| 18 | Short nail (HP:0001799) | 2.42631872 |
| 19 | Upper motor neuron abnormality (HP:0002127) | 2.40595421 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 2.38781709 |
| 21 | Papilledema (HP:0001085) | 2.38748578 |
| 22 | Apathy (HP:0000741) | 2.38664510 |
| 23 | Diminished motivation (HP:0000745) | 2.38389719 |
| 24 | Pustule (HP:0200039) | 2.34304055 |
| 25 | Recurrent viral infections (HP:0004429) | 2.33789103 |
| 26 | Dysostosis multiplex (HP:0000943) | 2.29065570 |
| 27 | Viral hepatitis (HP:0006562) | 2.28971088 |
| 28 | Metaphyseal cupping (HP:0003021) | 2.26442417 |
| 29 | Hand muscle atrophy (HP:0009130) | 2.22676318 |
| 30 | Abnormality of the thoracic spine (HP:0100711) | 2.21877916 |
| 31 | Interstitial pulmonary disease (HP:0006530) | 2.21144185 |
| 32 | Abnormality of the fingertips (HP:0001211) | 2.19918570 |
| 33 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.19587385 |
| 34 | Mucopolysacchariduria (HP:0008155) | 2.19587385 |
| 35 | Hyperacusis (HP:0010780) | 2.17271574 |
| 36 | Ulnar bowing (HP:0003031) | 2.15651199 |
| 37 | Deep venous thrombosis (HP:0002625) | 2.14333213 |
| 38 | Gastrointestinal inflammation (HP:0004386) | 2.14194666 |
| 39 | Distal lower limb amyotrophy (HP:0008944) | 2.13973679 |
| 40 | Ankyloglossia (HP:0010296) | 2.13267716 |
| 41 | Obstructive sleep apnea (HP:0002870) | 2.13088648 |
| 42 | Flat acetabular roof (HP:0003180) | 2.10830671 |
| 43 | Upper limb amyotrophy (HP:0009129) | 2.07432405 |
| 44 | Distal upper limb amyotrophy (HP:0007149) | 2.07432405 |
| 45 | Cerebral inclusion bodies (HP:0100314) | 2.06425095 |
| 46 | Abnormality of oral frenula (HP:0000190) | 2.06331131 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.06264673 |
| 48 | Deep palmar crease (HP:0006191) | 2.05547231 |
| 49 | Thrombocytosis (HP:0001894) | 2.05268983 |
| 50 | Papilloma (HP:0012740) | 2.02188099 |
| 51 | Verrucae (HP:0200043) | 2.02188099 |
| 52 | Bone pain (HP:0002653) | 2.02122197 |
| 53 | Abnormality of macrophages (HP:0004311) | 2.02023317 |
| 54 | Osteolytic defects of the hand bones (HP:0009699) | 2.01721992 |
| 55 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.01721992 |
| 56 | Nasal polyposis (HP:0100582) | 2.01332317 |
| 57 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.01237421 |
| 58 | Increased density of long bones (HP:0006392) | 2.00945597 |
| 59 | Resting tremor (HP:0002322) | 2.00220072 |
| 60 | Termporal pattern (HP:0011008) | 1.99855015 |
| 61 | Insidious onset (HP:0003587) | 1.99855015 |
| 62 | Thoracic kyphosis (HP:0002942) | 1.98641051 |
| 63 | Long palpebral fissure (HP:0000637) | 1.98563567 |
| 64 | Loss of speech (HP:0002371) | 1.97626788 |
| 65 | Abnormality of glycolipid metabolism (HP:0010969) | 1.96248209 |
| 66 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.96248209 |
| 67 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.96248209 |
| 68 | Rectal prolapse (HP:0002035) | 1.95407598 |
| 69 | Spinal cord lesions (HP:0100561) | 1.94582989 |
| 70 | Syringomyelia (HP:0003396) | 1.94582989 |
| 71 | Chronic obstructive pulmonary disease (HP:0006510) | 1.93539113 |
| 72 | Obstructive lung disease (HP:0006536) | 1.93539113 |
| 73 | Basal cell carcinoma (HP:0002671) | 1.92855167 |
| 74 | Neurofibrillary tangles (HP:0002185) | 1.92730271 |
| 75 | Inappropriate behavior (HP:0000719) | 1.92616936 |
| 76 | Thin bony cortex (HP:0002753) | 1.91910568 |
| 77 | Mitral valve prolapse (HP:0001634) | 1.91827566 |
| 78 | Striae distensae (HP:0001065) | 1.89236357 |
| 79 | Achilles tendon contracture (HP:0001771) | 1.89007208 |
| 80 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.86391278 |
| 81 | Mitral regurgitation (HP:0001653) | 1.85118479 |
| 82 | Abnormality of the nasal mucosa (HP:0000433) | 1.84835870 |
| 83 | Autoimmune thrombocytopenia (HP:0001973) | 1.84071753 |
| 84 | Dilatation of the ascending aorta (HP:0005111) | 1.83573541 |
| 85 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.83560737 |
| 86 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.83560737 |
| 87 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.83560737 |
| 88 | Genu recurvatum (HP:0002816) | 1.82234022 |
| 89 | Hypercortisolism (HP:0001578) | 1.81909049 |
| 90 | Deep philtrum (HP:0002002) | 1.81623258 |
| 91 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.81351601 |
| 92 | Cutaneous melanoma (HP:0012056) | 1.79737732 |
| 93 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.79734484 |
| 94 | Mediastinal lymphadenopathy (HP:0100721) | 1.79595709 |
| 95 | Fragile skin (HP:0001030) | 1.78984944 |
| 96 | Gastrointestinal carcinoma (HP:0002672) | 1.78354249 |
| 97 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.78354249 |
| 98 | Heterotopia (HP:0002282) | 1.77734551 |
| 99 | Amyotrophic lateral sclerosis (HP:0007354) | 1.77451461 |
| 100 | Slow saccadic eye movements (HP:0000514) | 1.77429670 |
| 101 | Increased connective tissue (HP:0009025) | 1.76922516 |
| 102 | Global brain atrophy (HP:0002283) | 1.76827041 |
| 103 | Progressive external ophthalmoplegia (HP:0000590) | 1.75758965 |
| 104 | Arterial tortuosity (HP:0005116) | 1.75724194 |
| 105 | Supranuclear gaze palsy (HP:0000605) | 1.75660747 |
| 106 | Bladder neoplasm (HP:0009725) | 1.75650818 |
| 107 | Bladder carcinoma (HP:0002862) | 1.75650818 |
| 108 | Chest pain (HP:0100749) | 1.75209133 |
| 109 | Somatic mutation (HP:0001428) | 1.74658856 |
| 110 | Distal lower limb muscle weakness (HP:0009053) | 1.74281889 |
| 111 | Aneurysm (HP:0002617) | 1.74123239 |
| 112 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.73903487 |
| 113 | J-shaped sella turcica (HP:0002680) | 1.73510895 |
| 114 | Broad face (HP:0000283) | 1.73509578 |
| 115 | Polycythemia (HP:0001901) | 1.72811058 |
| 116 | Enlarged penis (HP:0000040) | 1.71914635 |
| 117 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.71114952 |
| 118 | Spontaneous hematomas (HP:0007420) | 1.70987134 |
| 119 | Uterine leiomyosarcoma (HP:0002891) | 1.70730401 |
| 120 | Leiomyosarcoma (HP:0100243) | 1.70730401 |
| 121 | Fatigue (HP:0012378) | 1.69662985 |
| 122 | Renal cell carcinoma (HP:0005584) | 1.69650238 |
| 123 | Sparse lateral eyebrow (HP:0005338) | 1.69545663 |
| 124 | Persistence of primary teeth (HP:0006335) | 1.69505531 |
| 125 | Purpura (HP:0000979) | 1.69478921 |
| 126 | Multiple lipomas (HP:0001012) | 1.69312569 |
| 127 | Increased CSF protein (HP:0002922) | 1.69117489 |
| 128 | Abnormality of the Achilles tendon (HP:0005109) | 1.68398721 |
| 129 | T lymphocytopenia (HP:0005403) | 1.67864918 |
| 130 | Elbow flexion contracture (HP:0002987) | 1.67806110 |
| 131 | Myocardial infarction (HP:0001658) | 1.67726659 |
| 132 | Insomnia (HP:0100785) | 1.67633088 |
| 133 | Recurrent bronchitis (HP:0002837) | 1.67339895 |
| 134 | Emphysema (HP:0002097) | 1.66439140 |
| 135 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.66129799 |
| 136 | Disproportionate tall stature (HP:0001519) | 1.65995529 |
| 137 | Gastrointestinal stroma tumor (HP:0100723) | 1.65580627 |
| 138 | Chronic otitis media (HP:0000389) | 1.65500070 |
| 139 | Neuronal loss in central nervous system (HP:0002529) | 1.65215296 |
| 140 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.65103663 |
| 141 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.65075407 |
| 142 | Recurrent skin infections (HP:0001581) | 1.64827042 |
| 143 | Bicuspid aortic valve (HP:0001647) | 1.64377982 |
| 144 | Blue sclerae (HP:0000592) | 1.63891129 |
| 145 | Micronodular cirrhosis (HP:0001413) | 1.63816101 |
| 146 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.63105758 |
| 147 | Shallow orbits (HP:0000586) | 1.63023858 |
| 148 | Arterial thrombosis (HP:0004420) | 1.62516576 |
| 149 | Recurrent cutaneous fungal infections (HP:0011370) | 1.62455036 |
| 150 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.62455036 |
| 151 | Pathologic fracture (HP:0002756) | 1.62391758 |
| 152 | Vertebral arch anomaly (HP:0008438) | 1.62207455 |
| 153 | Vascular tortuosity (HP:0004948) | 1.62090038 |
| 154 | Gingivitis (HP:0000230) | 1.61892008 |
| 155 | Prominent nose (HP:0000448) | 1.61338519 |
| 156 | Fibrous tissue neoplasm (HP:0012316) | 1.61319182 |
| 157 | Asymmetry of the thorax (HP:0001555) | 1.60708799 |
| 158 | Pointed chin (HP:0000307) | 1.59638989 |
| 159 | Myositis (HP:0100614) | 1.58894485 |
| 160 | Axonal loss (HP:0003447) | 1.58556140 |
| 161 | Bulbar palsy (HP:0001283) | 1.58459551 |
| 162 | Increased variability in muscle fiber diameter (HP:0003557) | 1.57253699 |
| 163 | Abnormality of the lumbar spine (HP:0100712) | 1.56713445 |
| 164 | Trismus (HP:0000211) | 1.56668500 |
| 165 | Broad distal phalanx of finger (HP:0009836) | 1.55591833 |
| 166 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.55481453 |
| 167 | Mitral stenosis (HP:0001718) | 1.55057257 |
| 168 | Back pain (HP:0003418) | 1.54979946 |
| 169 | Polygenic inheritance (HP:0010982) | 1.54565994 |
| 170 | Menstrual irregularities (HP:0000858) | 1.54551846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.97420066 |
| 2 | TRIB3 | 3.85713021 |
| 3 | PKN2 | 3.43162973 |
| 4 | MAP3K10 | 2.90651451 |
| 5 | MAP4K1 | 2.62596952 |
| 6 | SMG1 | 2.56468397 |
| 7 | SIK2 | 2.45631005 |
| 8 | CDK12 | 2.36275236 |
| 9 | IRAK3 | 2.35306681 |
| 10 | EEF2K | 2.25335143 |
| 11 | GRK6 | 2.15904022 |
| 12 | MET | 2.14092478 |
| 13 | ALK | 2.13487079 |
| 14 | ERN1 | 2.05699139 |
| 15 | SCYL2 | 2.03991240 |
| 16 | PTK6 | 1.91577605 |
| 17 | RIPK4 | 1.84276650 |
| 18 | BMX | 1.73344812 |
| 19 | STK10 | 1.69161386 |
| 20 | LRRK2 | 1.69003777 |
| 21 | TYRO3 | 1.63417630 |
| 22 | NME2 | 1.62830751 |
| 23 | TAOK2 | 1.60204660 |
| 24 | MAP3K9 | 1.54165530 |
| 25 | CAMK1G | 1.51302432 |
| 26 | RIPK1 | 1.50367674 |
| 27 | MST1R | 1.48355267 |
| 28 | PDGFRA | 1.47488202 |
| 29 | CDK6 | 1.46587347 |
| 30 | ARAF | 1.38056665 |
| 31 | ZAP70 | 1.36955071 |
| 32 | LATS2 | 1.36611972 |
| 33 | BLK | 1.36303341 |
| 34 | FES | 1.36233913 |
| 35 | KSR2 | 1.35525074 |
| 36 | CSK | 1.33565959 |
| 37 | ICK | 1.23183057 |
| 38 | FGR | 1.22906951 |
| 39 | NEK2 | 1.18885501 |
| 40 | CAMK1D | 1.18380402 |
| 41 | MAP3K3 | 1.18116578 |
| 42 | TYK2 | 1.16758102 |
| 43 | MAP3K14 | 1.16717902 |
| 44 | MAP3K6 | 1.10739122 |
| 45 | IRAK2 | 1.09654209 |
| 46 | DMPK | 1.08374167 |
| 47 | RET | 1.05512409 |
| 48 | CAMKK1 | 1.05120993 |
| 49 | HIPK2 | 1.03069863 |
| 50 | HCK | 1.02006256 |
| 51 | NEK9 | 0.97668281 |
| 52 | MAP3K2 | 0.92997235 |
| 53 | PDGFRB | 0.92304322 |
| 54 | PAK4 | 0.92129714 |
| 55 | FGFR3 | 0.92122903 |
| 56 | EPHB1 | 0.90608841 |
| 57 | SYK | 0.89106478 |
| 58 | TGFBR2 | 0.88283089 |
| 59 | PASK | 0.88070428 |
| 60 | YES1 | 0.87656158 |
| 61 | JAK2 | 0.86950112 |
| 62 | EPHA2 | 0.86647411 |
| 63 | JAK1 | 0.84556102 |
| 64 | MARK2 | 0.84406610 |
| 65 | ITK | 0.83260547 |
| 66 | TAOK1 | 0.82398754 |
| 67 | JAK3 | 0.80695638 |
| 68 | MAP3K11 | 0.80067539 |
| 69 | NTRK1 | 0.79520760 |
| 70 | TBK1 | 0.77252811 |
| 71 | CDC42BPA | 0.76275830 |
| 72 | TTN | 0.75326495 |
| 73 | PRKCH | 0.74950770 |
| 74 | MTOR | 0.74913067 |
| 75 | MAP3K8 | 0.74386573 |
| 76 | STK11 | 0.73805267 |
| 77 | PRKD3 | 0.73202440 |
| 78 | EGFR | 0.72946517 |
| 79 | BTK | 0.72493958 |
| 80 | LCK | 0.72195166 |
| 81 | PRKD2 | 0.71952199 |
| 82 | MAP3K13 | 0.71387864 |
| 83 | CSF1R | 0.71275386 |
| 84 | BRAF | 0.70489905 |
| 85 | MOS | 0.70353009 |
| 86 | DDR2 | 0.69293391 |
| 87 | RPS6KA2 | 0.68290056 |
| 88 | CDK7 | 0.67953316 |
| 89 | PTK2B | 0.67226501 |
| 90 | TNK2 | 0.65218906 |
| 91 | PTK2 | 0.64122451 |
| 92 | MAP3K1 | 0.64001768 |
| 93 | RPS6KC1 | 0.63877497 |
| 94 | RPS6KL1 | 0.63877497 |
| 95 | PDK1 | 0.63563147 |
| 96 | KSR1 | 0.63363752 |
| 97 | STK24 | 0.62168187 |
| 98 | PNCK | 0.61634853 |
| 99 | FGFR4 | 0.60695350 |
| 100 | CDK4 | 0.59888478 |
| 101 | STK3 | 0.59622604 |
| 102 | PIM1 | 0.58968596 |
| 103 | MARK3 | 0.57369852 |
| 104 | RPS6KA6 | 0.55866456 |
| 105 | RPS6KB2 | 0.55632863 |
| 106 | MATK | 0.55073297 |
| 107 | BRD4 | 0.55018166 |
| 108 | PAK2 | 0.54839707 |
| 109 | CDK9 | 0.52772926 |
| 110 | ILK | 0.51444114 |
| 111 | DYRK1B | 0.51216342 |
| 112 | RPS6KA4 | 0.50500820 |
| 113 | MAP2K3 | 0.50022893 |
| 114 | UHMK1 | 0.49984531 |
| 115 | CDC7 | 0.48298981 |
| 116 | STK38 | 0.48267327 |
| 117 | TESK1 | 0.47859239 |
| 118 | IRAK4 | 0.47226631 |
| 119 | SGK3 | 0.45347960 |
| 120 | SIK3 | 0.44440643 |
| 121 | SIK1 | 0.44112640 |
| 122 | RPS6KA1 | 0.43981244 |
| 123 | GSK3A | 0.42950866 |
| 124 | DAPK1 | 0.41547107 |
| 125 | INSR | 0.41289465 |
| 126 | LATS1 | 0.41233105 |
| 127 | MAPK11 | 0.41013066 |
| 128 | FYN | 0.40980878 |
| 129 | TAOK3 | 0.40781540 |
| 130 | MAP3K5 | 0.40729385 |
| 131 | PIM2 | 0.40275192 |
| 132 | CDK19 | 0.40246320 |
| 133 | PDPK1 | 0.37211379 |
| 134 | WNK1 | 0.36608630 |
| 135 | RAF1 | 0.35030456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.23834559 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.13835031 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.87111991 |
| 4 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.77379021 |
| 5 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.73324177 |
| 6 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.72467021 |
| 7 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.71127954 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63892505 |
| 9 | Prion diseases_Homo sapiens_hsa05020 | 1.58281536 |
| 10 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.53925673 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.53715717 |
| 12 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.50464082 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.48359826 |
| 14 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.42478844 |
| 15 | Glioma_Homo sapiens_hsa05214 | 1.39394526 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.38944785 |
| 17 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.38580796 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34665610 |
| 19 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.33931381 |
| 20 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.31191573 |
| 21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.30407916 |
| 22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.29580972 |
| 23 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.28349137 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27228280 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.24509460 |
| 26 | Long-term potentiation_Homo sapiens_hsa04720 | 1.23812056 |
| 27 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.20664066 |
| 28 | Colorectal cancer_Homo sapiens_hsa05210 | 1.18168079 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17830816 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17438603 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.17375853 |
| 32 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.16853914 |
| 33 | Hepatitis C_Homo sapiens_hsa05160 | 1.16614662 |
| 34 | Endometrial cancer_Homo sapiens_hsa05213 | 1.15500442 |
| 35 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.14215688 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14119626 |
| 37 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.13974408 |
| 38 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.12144085 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.11466636 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.11177871 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09267123 |
| 42 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09252298 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.02578784 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.01080622 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.99472407 |
| 46 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.98871245 |
| 47 | Adherens junction_Homo sapiens_hsa04520 | 0.97279942 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.97038834 |
| 49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.95898703 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94487064 |
| 51 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.93089663 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93028787 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.92614681 |
| 54 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.92123701 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91151462 |
| 56 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.91054134 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.89009262 |
| 58 | Endocytosis_Homo sapiens_hsa04144 | 0.88357132 |
| 59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87893489 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.87481999 |
| 61 | Focal adhesion_Homo sapiens_hsa04510 | 0.85390640 |
| 62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.84805771 |
| 63 | Apoptosis_Homo sapiens_hsa04210 | 0.84464728 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84375790 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.83888535 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83406599 |
| 67 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.83226136 |
| 68 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.82436557 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82288459 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81578153 |
| 71 | Prostate cancer_Homo sapiens_hsa05215 | 0.80837187 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80711683 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80672741 |
| 74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79055049 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 0.78987514 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.78717588 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78500432 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77992960 |
| 79 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.77886289 |
| 80 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.77328489 |
| 81 | Measles_Homo sapiens_hsa05162 | 0.76693348 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75961002 |
| 83 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.74727274 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.74310272 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74286930 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73228877 |
| 87 | Long-term depression_Homo sapiens_hsa04730 | 0.72647390 |
| 88 | Renin secretion_Homo sapiens_hsa04924 | 0.71853536 |
| 89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71706582 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71473350 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70845391 |
| 92 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.69324626 |
| 93 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69191242 |
| 94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68387921 |
| 95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67902812 |
| 96 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.67851664 |
| 97 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.67689828 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66485820 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65420274 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64678229 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63133906 |
| 102 | Influenza A_Homo sapiens_hsa05164 | 0.62810192 |
| 103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62559744 |
| 104 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.62207757 |
| 105 | Melanogenesis_Homo sapiens_hsa04916 | 0.62018107 |
| 106 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61826454 |
| 107 | Gap junction_Homo sapiens_hsa04540 | 0.61805010 |
| 108 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.59484261 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59380164 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58915847 |
| 111 | Malaria_Homo sapiens_hsa05144 | 0.57994195 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57758908 |
| 113 | Legionellosis_Homo sapiens_hsa05134 | 0.57277020 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56992364 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56826637 |
| 116 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56402897 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55084771 |
| 118 | Cell cycle_Homo sapiens_hsa04110 | 0.54145527 |
| 119 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54121442 |
| 120 | Melanoma_Homo sapiens_hsa05218 | 0.53513101 |
| 121 | Phagosome_Homo sapiens_hsa04145 | 0.53505431 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50760762 |
| 123 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.50457011 |

